News

Investing.com - U.S. stock index futures were mixed on Wednesday, with the S&P 500 and Nasdaq edging higher after a bruising two-day selloff in technology and semiconductor shares. Investors were also looking ahead to earnings from memory chipmaker Micron for fresh clues on the outlook for artificial intelligence-related demand.

The war in Iran has had a trickle-down effect on inflation and interest rates.

Chinese tech giant Alibaba has filed a federal lawsuit against the Defense Department for designating it a military-linked firm.

BlackRock Managing Director Robert Mitchnick says AI investment is draining capital away from Bitcoin, with weakness evident in Bitcoin’s 20% slide over the past month. Mitchnick Says US Debt Fears Could Reignite Bitcoin Around The Midterms Mitchnick argued on Monday that Bitcoin’s weak stretch since October has little to do with crypto-specific problems and everything to do with capital flooding into AI instead. He noted gold and other traditional inflation hedges have faced the same pressure a

FedEx (FDX) shares fell early Wednesday after the company provided a calendar-year earnings outlook

FedEx touts premium revenue mix, cost savings and stronger cash flow as it resets its calendar 2026 outlook after a solid fiscal fourth quarter.

A three-year high for inflation may force the Federal Open Market Committee (FOMC) into action.

Gold prices fell, extending the previous session's losses as a stronger U.S. dollar and growing expectations of interest-rate hikes this year weighed on sentiment. "Limited support came from rising Treasury bonds as lower energy prices ease concerns about inflation," analysts at Saxo Bank said.

Investors are looking forward to another week of chip-stock reveals. Qualcomm has its investor conference, and Micron reports earnings a day after a sharp decline in its stock. The Federal Reserve meanwhile will get another data point on the inflation picture, with the PCE (price consumption expenditures) index.

These two AI stocks are also great dividend stocks.

FedEx Corp (FDX) reports robust revenue growth and highest operating margin in four years, despite challenges from fuel costs and global trade policies.

FedEx reported strong quarterly results, driven by growth in package volumes and yields as the company focuses on high-margin logistics business. The post FedEx boost revenue behind premium parcel, freight volumes appeared first on FreightWaves.

While the top- and bottom-line numbers for FedEx (FDX) give a sense of how the business performed in the quarter ended May 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Costco Wholesale keeps proving its critics wrong. While tariff fears, rising gas prices, and a shaky global economy have rattled many retailers, the warehouse giant keeps delivering. Its latest earnings report and monthly sales update paint a picture of a company gaining ground. And ...

Nike announced a CFO transition and said fourth-quarter results remain on track, excluding a one-time tariff refund benefit.

FedEx stock sinks despite an earnings beat.

FedEx stock sinks despite an earnings beat.

FedEx (FDX) delivered earnings and revenue surprises of +6.81% and +3.42%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?

Shares of shipper FedEx fell after the company beat expectations for fourth quarter earnings and revenue and sees continued profit growth this year. Shares fell 4.4% in after hours trading to $303.29. FedEx reported fourth quarter revenue of $25 billion and adjusted earnings of $6.21 a share.

Chief Executive Raj Subramaniam said FedEx’s growth strategy is working, and with the spinoff of its freight division, the company is positioned to further optimize its network and lower costs.

The iShares Core MSCI EAFE ETF (NYSEARCA:IEFA) has quietly become one of the best-performing core holdings in U.S. investor portfolios this year, climbing roughly 10.5% year to date and roughly 24% over the past 12 months to around $97. With 7 basis points in fees and roughly 2,500 developed-market holdings across Europe, Japan, and Australia, ... If the Fed Cuts Again, IEFA Could Rally Further. Here’s Your Monitoring Checklist.

Freight giants have pivoted to healthcare logistics, which they see as recession-proof.

With odds of a 2026 rate hike getting shorter, the Fidelity Dividend ETF For Rising Rates is a fund to consider.

I keep hitting the buy button on Grab (NASDAQ:GRAB) and I am not done. While Wall Street obsesses over June tech prices and broader indices wobble on inflation worries, I am quietly adding shares of a Southeast Asian super-app that, in my view, is being mispriced as a volatile penny stock when the underlying business ... Here Is the 1 Dirt-Cheap Super-App Monopoly I Keep Accumulating on Repeat

Nike Inc. CEO Elliott Hill admitted that the company’s restructuring process is not progressing as swiftly as initially planned. Hill attributed the delay to the magnitude of Nike’s challenges, amplified by U.S. tariffs and increasing oil prices that have affected consumer spending. “What I didn’t realize until I got in is the amount of work that needed to be done and the amount of time [it would take] to get us to where we are and, more importantly, where we want to go,” Hill told in an intervi

The Fed’s pivot toward a rate-hike bias changes the math for a 67-year-old with $1.5 million in a 401k. Bond reinvestment risk just got more interesting, but equity duration got more dangerous. My answer is three Dividend Kings whose payouts have survived every rate regime since the Eisenhower administration. Here is the safety case for ... 67 With $1.5 Million. Here Are My 3 Defensive Anchors

Chinese tech and e-commerce giant Alibaba sued ‌the U.S. Department of ‌Defense for designations including saying it was ​a "Chinese military company," according to a court filing on Tuesday. "The determinations have no basis in ‌fact or law," ⁠Alibaba said in its lawsuit. "Alibaba is governed by ⁠an independent board, none of whom has any military affiliation."

Despite increased uncertainty, Coca-Cola and Walmart keep offering reliability.

When Dave Ricks became chief executive officer of Eli Lilly & Co. in 2017, he was facing an industry under siege. Americans held drug companies in lower esteem than airlines, law firms and even the federal government. President Donald Trump, then starting his first term, was excoriating them for their high prices. A mounting number of reports showed that soaring costs were even forcing some diabetics to ration insulin. Ricks, the 11th CEO in Lilly's 150-year history, concedes that one was a public-relations nightmare. Almost a decade later, the mood at Lilly has shifted dramatically. The company's hit diabetes shot, Mounjaro, and obesity shot, Zepbound, have transformed its fortunes and, in many ways, its public image. We speak with Madison Muller, Bloomberg News Healthcare Reporter, for a closer look.

Saturna Capital Chief Investment Officer Scott Klimo joined Steve Darling from Proactive to discuss the Saturna Global Equity ETF, the principles of Shariah-compliant investing, and how the rapid growth of artificial intelligence is reshaping valuations and opportunities across global markets. Klimo explained that the actively managed ETF applies Islamic investment guidelines that exclude sectors such as conventional banking, insurance, gambling, tobacco, alcohol, and weapons. In addition to those sector screens, the strategy also emphasizes companies with low debt levels, a factor Klimo said can signal strong cash generation, disciplined capital allocation, and durable business models. The conversation also focused on the impact of AI on technology investing. Klimo noted that major technology companies such as Alphabet, Amazon, and Microsoft are evolving from traditionally asset-light businesses into far more capital-intensive operators as they commit massive sums to AI infrastructure, data centers, and compute capacity. Beyond the large-cap AI leaders, Klimo highlighted a broader group of companies benefiting from the AI buildout, including ASML, Taiwan Semiconductor, Samsung Electronics, and Japan’s Fujikura, all of which play important roles in chip manufacturing, semiconductor equipment, and data-center connectivity. The discussion also touched on the pharmaceutical sector, where Klimo sees long-term value despite recent market weakness. He said healthcare companies can provide portfolio balance and defensive characteristics, even as investors continue to weigh regulatory uncertainty and shifting sentiment toward the sector. Looking at the broader market backdrop, Klimo pointed to continued geopolitical uncertainty, inflation trends, and energy prices as important factors to monitor. At the same time, he said he remains generally constructive on the market outlook, supported by resilient corporate earnings and the long-term productivity gains expected from AI adoption. #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews #SaturnaCapital #ShariahInvesting #ArtificialIntelligence #ETFInvesting #GlobalEquities #TechInvesting #AIInfrastructure #Semiconductors #HealthcareStocks #MarketOutlook